Tandem Diabetes Care (TNDM) Operating Income (2013 - 2026)
Tandem Diabetes Care posted quarterly Operating Income of -$17.4 million for Q1 2026, up 85.58% year-on-year from -$9.4 million in Q1 2025, and down 310.2% on a QoQ basis from $8.3 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Operating Income data on file, last reported at -$17.4 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 85.58% year-over-year to -$17.4 million; the trailing twelve-month figure through Mar 2026 stood at -$83.8 million (up 53.0% YoY), and the FY2025 full-year result was -$187.3 million, down 88.91% from the prior year.
- Operating Income for Q1 2026 stood at -$17.4 million, down from $8.3 million in the prior quarter.
- Across five years, Operating Income topped out at $8.3 million in Q4 2025 and bottomed at -$127.8 million in Q1 2023.
- The 5-year median for Operating Income is -$30.8 million (2024), against an average of -$37.1 million.
- The widest annual swing landed in 2023, when Operating Income tumbled 733.34%; it then soared 1527.54% in 2025.
- A 5-year view of Operating Income shows it stood at -$17.8 million in 2022, then tumbled by 97.22% to -$35.1 million in 2023, then soared by 98.34% to -$581000.0 in 2024, then jumped by 1527.54% to $8.3 million in 2025, then slumped by 310.2% to -$17.4 million in 2026.
- The last three Operating Income figures came in at -$17.4 million (Q1 2026), $8.3 million (Q4 2025), and -$22.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | -17.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.43 Mn |
| Dec 31, 2025 | 8.29 Mn |
| Sep 30, 2025 | -22.86 Mn |
| Jun 30, 2025 | -51.81 Mn |
| Mar 31, 2025 | -120.88 Mn |
| Dec 31, 2024 | -581,000.00 |
| Sep 30, 2024 | -26.09 Mn |
| Jun 30, 2024 | -30.77 Mn |
| Mar 31, 2024 | -41.68 Mn |
| Dec 31, 2023 | -35.06 Mn |
| Sep 30, 2023 | -31.55 Mn |
| Jun 30, 2023 | -38.81 Mn |
| Mar 31, 2023 | -127.82 Mn |
| Dec 31, 2022 | -17.78 Mn |
| Sep 30, 2022 | -47.49 Mn |
| Jun 30, 2022 | -12.24 Mn |
| Mar 31, 2022 | -15.34 Mn |
| Dec 31, 2021 | 12.74 Mn |
| Sep 30, 2021 | 7.72 Mn |
| Jun 30, 2021 | 5.43 Mn |
| Mar 31, 2021 | -3.24 Mn |
| Dec 31, 2020 | 18.66 Mn |
| Sep 30, 2020 | -1.01 Mn |
| Jun 30, 2020 | -12.04 Mn |
| Mar 31, 2020 | -13.57 Mn |
| Dec 31, 2019 | 2.14 Mn |
| Sep 30, 2019 | -6.00 Mn |
| Jun 30, 2019 | -1.87 Mn |
| Mar 31, 2019 | -11.00 Mn |
| Dec 31, 2018 | 560,000.00 |
| Sep 30, 2018 | -15.71 Mn |
| Jun 30, 2018 | -14.00 Mn |
| Mar 31, 2018 | -15.49 Mn |
| Dec 31, 2017 | -9.58 Mn |
| Sep 30, 2017 | -13.17 Mn |
| Jun 30, 2017 | -18.97 Mn |
| Mar 31, 2017 | -21.23 Mn |
| Dec 31, 2016 | -13.35 Mn |
| Sep 30, 2016 | -28.41 Mn |
| Jun 30, 2016 | -17.05 Mn |
| Mar 31, 2016 | -19.24 Mn |
| Dec 31, 2015 | -11.22 Mn |
| Sep 30, 2015 | -18.70 Mn |
| Jun 30, 2015 | -18.67 Mn |
| Mar 31, 2015 | -20.41 Mn |
| Dec 31, 2014 | -17.50 Mn |
| Sep 30, 2014 | -19.01 Mn |
| Jun 30, 2014 | -18.32 Mn |
| Mar 31, 2014 | -20.84 Mn |
| Dec 31, 2013 | -16.46 Mn |
| Sep 30, 2013 | -12.13 Mn |
| Jun 30, 2013 | -13.68 Mn |
| Mar 31, 2013 | -7.17 Mn |